France Flow Cytometry Market Size & Outlook, 2023-2030
France flow cytometry market, 2018-2030 (US$M)
Related Markets
France flow cytometry market highlights
- The France flow cytometry market generated a revenue of USD 186.9 million in 2023 and is expected to reach USD 297.7 million by 2030.
- The France market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 186.9 million |
| Market revenue in 2030 | USD 297.7 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, France accounted for 4.3% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 403.0 million by 2030.
Instruments was the largest segment with a revenue share of 34.51% in 2023. Horizon Databook has segmented the France flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
France flow cytometry market was valued at USD 197.3 million in 2021 and is expected to grow at a CAGR of 6.66% during the forecast period, to reach an expected value of USD 386.2 million in 2030. Over the past decades, the number of biopharmaceutical companies in France significantly increased.
France biopharmaceutical players such as Sanofi, Servier, Pierre Fabre, and Ipsen are focused on the development of novel therapies for cancer, hematological disorders, and cardiovascular diseases, among others.
Increasing number of research initiatives by these research organizations and companies is expected to significantly boost the demand for flow cytometry products for research purposes, thus creating a favorable environment for flow cytometry market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France flow cytometry market size, by product, 2018-2030 (US$M)
France Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
